The United States represents a significant share of the Nabumetone Market, supported by the high prevalence of osteoarthritis, rheumatoid arthritis, and other chronic musculoskeletal disorders. Growing demand for effective nonsteroidal anti-inflammatory drugs (NSAIDs) among the aging population continues to drive market growth. According to market estimates, the Nabumetone Market size is...